Skip to main content
Premium Trial:

Request an Annual Quote

GeneGo Licenses MetaCore Data Analysis Platform to Organon

NEW YORK, April 19 (GenomeWeb News) - GeneGo has licensed its MetaCore data analysis platform to N.V. Organon, a drug firm headquartered in the Ntherlands and the US, St. Joseph, Mich.-based GeneGo said today.

 

Organon plans to use MetaCore in preclinical research across several therapeutic areas and departments.

 

MetaCore includes a manually curated database covering cellular functions of humans and a number of model organisms, as well as information on over 3,000 human diseases and drugs acting on pathway targets.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.